Abiopharma

ACM RESEARCH, INC. (ACMR) Reports the reporting period Financial Results ACM RESEARCH, INC. (ACMR) announced its financial results for the period ending the reporting period. Key Financial Highlights:

• Revenue: $225 million
• Net Income: Not disclosed
• EPS: Not disclosed
• Cash and equivalents: Not disclosed
  • expected by ACM. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. ACM undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in its expectations with regard to these forward-looking statements or the occurrence of unanticipated events.© ACM Research, Inc. The ACM Research logo is a trademark of ACM Research, Inc. For convenience, this trademark appears in this press release without a ™ symbol, but that practice does not mean that ACM will not assert, to the fullest extent under applicable law, its rights to such trademark.For investor and media inquiries, please contact:In the United States: The Blueshirt GroupSteven C. Pelayo, CFA+1 (360) 808-5154